Ironwood Pharmaceuticals, Inc. · NASDAQ:IRWD
Armistice Capital, LLC reported a 8.43% stake in Ironwood Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Armistice Capital, LLC reported a 8.43% stake in Ironwood Pharmaceuticals, Inc., 13,932,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 8.43%
- Shares
- 13,932,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 8.43% | 13,932,000 |
| Steven Boyd | 8.43% | 13,932,000 |
Source
Related
- Ironwood Pharmaceuticals, Inc.
- Armistice Capital, LLC
- Ironwood Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2025
- Schedule 13G/A · Armistice Capital, LLC · Feb 14, 2025
- Form 4 · Denner Alexander J · Sep 17, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Silber Jeffrey · Jul 22, 2026
- Form 4 · Silver Ronald · Jul 9, 2026